EDMOND DE ROTHSCHILD HOLDING S.A. - ACASTI PHARMA INC ownership

ACASTI PHARMA INC's ticker is ACST and the CUSIP is 00430K402. A total of 3 filers reported holding ACASTI PHARMA INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
EDMOND DE ROTHSCHILD HOLDING S.A. ownership history of ACASTI PHARMA INC
ValueSharesWeighting
Q1 2022$15,000
-40.0%
12,5000.0%0.00%
-100.0%
Q3 2021$25,000
-55.4%
12,500
-87.5%
0.00%0.0%
Q2 2021$56,000
-6.7%
100,0000.0%0.00%
-50.0%
Q1 2021$60,000100,0000.00%
Other shareholders
ACASTI PHARMA INC shareholders Q1 2022
NameSharesValueWeighting ↓
Perceptive Advisors 236,559$594,0000.04%
INTACT INVESTMENT MANAGEMENT INC. 89,490$287,0000.01%
BANK OF MONTREAL /CAN/ 210,484$537,0000.00%
DEUTSCHE BANK AG\ 215$00.00%
Tower Research Capital LLC (TRC) 200$1,0000.00%
CITIGROUP INC 30$00.00%
MORGAN STANLEY 18$00.00%
Renaissance Technologies 20,900$53,0000.00%
ROYAL BANK OF CANADA 588$1,0000.00%
LADENBURG THALMANN FINANCIAL SERVICES INC. 400$1,0000.00%
View complete list of ACASTI PHARMA INC shareholders